ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Accrued Liabilities
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Other Accrued Liabilities of $1.10 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2017-11-09
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2017-09-30 was $944.00K, a 376.77% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2017-06-30 was -$19.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2017-03-31 was $179.00K, a 73.24% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2016-12-31 was -$218.00K, a 826.67% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2016 was $215.00K, a 26.62% decline from fiscal 2015.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2015 was $293.00K, a 7225.00% increase from fiscal 2014.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2014 was $4.00K, a 96.15% decline from fiscal 2013.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2013 was $104.00K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 4 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $944.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $925.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.10M 10-Q · filed 2017-11-09 | $886.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2017-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $160.00K 10-Q · filed 2017-08-07 | -$58.00K derived: sum of 3 quarters · filed 2017-08-07 | $140.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2017-03-31 | $179.00K 10-Q · filed 2017-05-04 | -$39.00K derived: sum of 2 quarters · filed 2017-05-04 | $159.00K derived: sum of 3 quarters · filed 2017-11-09 | -$275.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-12-31 | -$218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$20.00K derived: sum of 2 quarters · filed 2017-11-09 | -$454.00K derived: sum of 3 quarters · filed 2017-11-09 | $215.00K 10-K · filed 2017-03-09 | ||||
| 2016-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$236.00K derived: sum of 2 quarters · filed 2017-11-09 | $433.00K 10-Q · filed 2017-11-09 | $463.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | -$434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $235.00K 10-Q · filed 2017-08-07 | $265.00K derived: sum of 3 quarters · filed 2017-08-07 | -$2.72M derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2016-03-31 | $669.00K 10-Q · filed 2017-05-04 | $699.00K derived: sum of 2 quarters · filed 2017-05-04 | -$2.29M derived: sum of 3 quarters · filed 2017-05-04 | $733.00K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$2.95M derived: sum of 2 quarters · filed 2017-03-09 | $64.00K derived: sum of 3 quarters · filed 2017-03-09 | $293.00K 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | -$2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $34.00K derived: sum of 2 quarters · filed 2016-11-04 | $263.00K 10-Q · filed 2016-11-04 | $1.98M 10-Q · filed 2015-11-06 | -$173.00K derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $3.25M 10-Q · filed 2016-08-08 | $2.81M derived: sum of 3 quarters · filed 2017-03-09 | $2.90M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2015-03-31 | $229.00K 10-Q · filed 2016-05-06 | $1.14M 10-Q · filed 2015-05-11 | -$207.00K derived: sum of 2 quarters · filed 2017-03-09 | -$122.00K derived: sum of 3 quarters · filed 2017-03-09 | -$324.00K derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2014-12-31 | -$436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$351.00K derived: sum of 2 quarters · filed 2017-03-09 | -$553.00K derived: sum of 3 quarters · filed 2017-03-09 | $4.00K 10-K · filed 2017-03-09 | $626.00K 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$117.00K derived: sum of 2 quarters · filed 2015-11-06 | $440.00K 10-Q · filed 2015-11-06 | $2.00K derived: sum of 4 quarters · filed 2016-03-04 | ||||
| 2014-06-30 | -$202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $355.00K 10-Q · filed 2015-08-07 | -$83.00K derived: sum of 3 quarters · filed 2016-03-04 | |||||
| 2014-03-31 | $557.00K 10-Q · filed 2015-05-11 | $119.00K derived: sum of 2 quarters · filed 2016-03-04 | ||||||
| 2013-12-31 | -$438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $104.00K 10-K · filed 2016-03-04 | $312.00K 10-K · filed 2015-02-26 | |||||
| 2013-09-30 | $542.00K 10-Q · filed 2014-11-12 | |||||||
| 2012-12-31 | $120.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |